SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-043911
Filing Date
2023-04-11
Accepted
2023-04-11 12:13:05
Documents
9
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm233915d4_def14a.htm DEF 14A 291381
3 GRAPHIC j2339153_aa001.jpg GRAPHIC 6315
4 GRAPHIC tm233915d4_coverimg001.jpg GRAPHIC 2380
5 GRAPHIC tm233915d4_def14aimg03.jpg GRAPHIC 3578
6 GRAPHIC tm233915d4_def14aimg04.jpg GRAPHIC 2263
7 GRAPHIC tm233915d4_def14aimg05.jpg GRAPHIC 4922
8 GRAPHIC tm233915d4_def14aimg06.jpg GRAPHIC 7401
9 GRAPHIC tm233915d4_defa14aimg001.jpg GRAPHIC 8158
10 GRAPHIC tm233915d4_defa14aimg002.jpg GRAPHIC 1489
  Complete submission text file 0001104659-23-043911.txt   344015
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 811-06565 | Film No.: 23812847